| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | - | 6.180 | 96.778 | 111.912 |
| Total Income - EUR | - | - | - | - | - | - | - | 6.180 | 96.778 | 111.912 |
| Total Expenses - EUR | - | - | - | - | - | - | - | 827 | 29.881 | 39.059 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | - | 5.353 | 66.896 | 72.853 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | - | 5.292 | 66.074 | 69.985 |
| Employees | - | - | - | - | - | - | - | 1 | 1 | 1 |
Check the financial reports for the company - Markmed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | - | 40.152 | 100.900 | 89.167 |
| Current Assets | - | - | - | - | - | - | - | 6.262 | 2.708 | 59.853 |
| Inventories | - | - | - | - | - | - | - | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | - | - | 0 | 686 | 828 |
| Cash | - | - | - | - | - | - | - | 6.262 | 2.022 | 59.025 |
| Shareholders Funds | - | - | - | - | - | - | - | 5.333 | 71.390 | 140.976 |
| Social Capital | - | - | - | - | - | - | - | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | - | 41.081 | 31.813 | 8.044 |
| Income in Advance | - | - | - | - | - | - | - | 0 | 404 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Markmed S.r.l.